首页 正文

Current Perspectives of Anticoagulation in Patients With COVID-19

{{output}}
Thromboembolism and myocardial injury is common in patients with COVID-19. Low-molecular-weight heparin appears to be associated with a good prognosis in patients with COVID-19 and has the ability to reduce coagulation and inflammation markers. Hospitalized pa... ...